Department of Otolaryngology-Head and Neck Surgery, Ear & Hearing, Amsterdam University Medical Centres, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam.
Department of Otolaryngology-Head and Neck Surgery, Erasmus University Medical Center, Rotterdam.
Otol Neurotol. 2020 Sep;41(8):1094-1101. doi: 10.1097/MAO.0000000000002770.
To coordinate and align the content for registration of cholesteatoma care.
Systematic Delphi consensus procedure, consisting three rounds: two written sessions followed by a face-to-face meeting. Before this procedure, input on important patient outcomes was obtained. Consensus was defined as at least 80% agreement by participants. Hundred-thirty-six adult patients who had undergone cholesteatoma surgery and all ENT surgeons of the Dutch ENT Society were invited. The consensus rounds were attended by ENT surgeons with cholesteatoma surgery experience. Feasibility and acceptability of outcome measures and reporting agreements were assessed in round 1 by 150 ENT surgeons. In round 2 definitions were narrowed and context information to interpret outcome measure were questioned. In round 3, the results, amendments, and the open-ended points were discussed to reach agreement.
Most important outcome measures are: 1) the presence or absence of a cholesteatoma in the first 5 years after surgical removal of cholesteatoma, 2) hearing level after surgical removal of cholesteatoma, and 3) the documented assessment of patient's complaints with a validated patient reported outcome measures questionnaire (PROM). Furthermore, consensus was reached on the registration of cholesteatoma type (residual/recurrent), localization of cholesteatoma, and reporting of the presence of cholesteatoma in the follow-up.
Consensus was reached on the content and method of registration of cholesteatoma care based on patient's and ENT surgeons input. Three outcome measures were defined. National agreements on the method and content of registration will facilitate monitoring and feedback to the ENT surgeon about the cholesteatoma care.
为了协调和统一胆脂瘤护理的注册内容。
采用系统 Delphi 共识程序,包括三轮:两轮书面会议和一轮面对面会议。在此程序之前,获得了重要患者结局的投入。共识定义为参与者至少 80%的一致同意。邀请了 136 名接受过胆脂瘤手术的成年患者和荷兰耳鼻喉科协会的所有耳鼻喉科外科医生。有胆脂瘤手术经验的耳鼻喉科外科医生参加了共识轮次。在第一轮中,由 150 名耳鼻喉科外科医生评估了结局测量和报告协议的可行性和可接受性。在第二轮中,缩小了定义,并对解释结局测量的上下文信息提出了质疑。在第三轮中,讨论了结果、修正案和开放式要点,以达成一致。
最重要的结局测量包括:1)在胆脂瘤切除后的前 5 年内是否存在胆脂瘤,2)胆脂瘤切除后的听力水平,3)使用经过验证的患者报告结局测量问卷(PROM)对患者的抱怨进行有记录的评估。此外,还就胆脂瘤类型(残留/复发)的登记、胆脂瘤的定位以及在随访中报告胆脂瘤的存在达成了共识。
根据患者和耳鼻喉科外科医生的投入,就胆脂瘤护理的注册内容和方法达成了共识。定义了三个结局测量。关于注册方法和内容的国家协议将有助于监测和向耳鼻喉科外科医生反馈胆脂瘤护理情况。